Revenue: The sum of all revenue fields included for a company's operating activities.
CASI Pharmaceuticals Inc. (CASI) had Revenue of $28.54M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$28.54M |
$-39.26M |
|
$17.39M |
|
$11.15M |
|
$68.16M |
|
$-39.62M |
|
$1.55M |
|
$-38.07M |
|
$-38.07M |
|
$-38.07M |
|
$-39.26M |
|
$-39.26M |
|
$-38.07M |
|
$-39.62M |
|
$-37.29M |
|
15.34M |
|
15.34M |
|
$-2.56 |
|
$-2.56 |
|
| Balance Sheet Financials | |
$39.58M |
|
$7.87M |
|
$14.10M |
|
$53.67M |
|
$36.45M |
|
-- |
|
$15.37M |
|
$51.82M |
|
$1.85M |
|
$1.61M |
|
$1.85M |
|
15.49M |
|
| Cash Flow Statement Financials | |
$-29.22M |
|
$11.24M |
|
$15.43M |
|
$17.08M |
|
$13.47M |
|
$-3.62M |
|
$1.31M |
|
$-0.72M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
-- |
|
9.93 |
|
39.06% |
|
-138.84% |
|
-138.84% |
|
-130.67% |
|
-133.40% |
|
-137.57% |
|
$-29.45M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
3.31 |
|
1.86 |
|
196.27 |
|
-2120.90% |
|
-2433.85% |
|
-73.14% |
|
-2120.91% |
|
$0.12 |
|
$-1.92 |
|
$-1.91 |
|